Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 20 symbols : Abbv save search
AbbVie Gains Access to Pulmonary Fibrosis Antibody with $225M DJS Buy
Published: 2022-10-20 (Crawled : 18:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.02%
H: 0.61%
C: -0.16%
fibrosis antibody
AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline
Published: 2022-10-20 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.47%
H: 0.45%
C: 0.07%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.02%
H: 0.61%
C: -0.16%
immunology
CytoDyn Announces Appointment of Additional Directors with Industry Experience
Published: 2022-10-20 (Crawled : 13:00) - globenewswire.com
CYDY | $0.1509 0.06% 810K
|
Manufacturing
|
| O: -1.07%
H: 3.38%
C: 1.08%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.02%
H: 0.61%
C: -0.16%
Tyrosine Kinase Inhibitors Market Size to Grow by USD 19.07 Bn, North America to Account for 38% of Market Growth - Technavio
Published: 2022-10-20 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 4.6%
H: 0.47%
C: 0.4%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.41%
H: 2.96%
C: 2.96%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.82%
H: 0.57%
C: -0.43%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.47%
H: 0.45%
C: 0.07%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.42%
H: 0.64%
C: -0.38%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.02%
H: 0.61%
C: -0.16%
PBYI | $5.01 0.4% 0.4% 290K
|
Health Technology
|
| O: 0.93%
H: 2.07%
C: -0.92%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.54%
H: 2.07%
C: 1.27%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.26%
H: 0.61%
C: -0.04%
america growth market